Adjuvant chemotherapy for stage II nonseminomatous germ-cell tumors

Seminars in Urologic Oncology

Volumn 20, Issue 4, 2002, Pages 239-243

  Kondagunta, G Varuni ^a,b   Motzer, Robert J ^a,b,c  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Department of Molecular Biology and Genetics   (United States)

^c Memorial Hospital   (United States)

Author keywords

Adjuvant therapy; Nonseminomatous germ cell tumors; Review; Stage II

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; ETOPOSIDE; VINBLASTINE;

CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; DRUG EFFICACY; HUMAN; LUNG TOXICITY; LYMPH NODE DISSECTION; MALE; NEPHROTOXICITY; NEUROTOXICITY; NON SEMINOMATOUS GERMINOMA; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; SKIN TOXICITY; STOMATITIS; TREATMENT INDICATION;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; ETOPOSIDE; GERMINOMA; HUMANS; LYMPH NODE EXCISION; MALE; TESTICULAR NEOPLASMS;

EID: 0036864942     PISSN: 10810943     EISSN: None     Source Type: Journal    
DOI: 10.1053/suro.2002.36975     Document Type: Review

References (33)

1. DeVita VJ, Hellman S, Rosenberg SA (eds): Cancer: Principles and Practice. Philadelphia, PA, Lippincott, Williams and Wilkins, 2001
2. Cheng E, Cvitkovic E, Wittes RE, et al: Germ cell tumors(II): VAB II in metastatic testicular cancer. Cancer 42:2162-2168, 1978
3. Einhorn LH, Donohue J: Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. Ann Intern Med 87:293-298, 1977
4. Reynolds TF, Vugrin D, Cvitkovic E, et al: VAB-3 combination chemotherapy of metastatic testicular cancer. Cancer 48:888-898, 1981
5. Vugrin D, Whitmore WF, Cvitkovic E, et al: Adjuvant chemotherapy combination of vinblastine, actinomycin D, bleomycin, and chlorambucil following retroperitoneal lymph node dissection for stage II testis tumor. Cancer 47:840-844, 1981
6. Bajorin DF, Sarosdy MF, Pfister DG, et al: Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: A multi-institutional study. J Clin Oncol 11:598-606, 1993
7. Bosl GJ, Geller NL, Bajorin D, et al: A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors. J Clin Oncol 6:1231-1238, 1988
8. Einhorn LH, Williams SD, Lochrer PJ, et al: Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: A Southeastern Cancer Study Group protocol. J Clin Oncol 7:387-391, 1989
9. Loehrer PJ Sr, Johnson D, Elson P, et al: Importance of bleomycin in favorable-prognosis disseminated germ cell tumors: An Eastern Cooperative Oncology Group trial. J Clin Oncol 13:470-476, 1995
10. Xiao H, Mazumdar M, Bajorin DF, et al: Long-term follow-up of patients with good-risk germ cell tumors treated with etoposide and cisplatin. J Clin Oncol 15:2553-2558, 1997
11. Donohue JP, Einhorn LH, Perez JM: Improved management of nonseminomatous testis tumors. Cancer 42:2903-2908, 1978
12. Foster RS, Roth BJ: Clinical stage I nonseminoma: Surgery versus surveillance. Semin Oncol 25:145-153, 1998
13. Johnson DE, Bracken RB, Blight EM: Prognosis for pathologic stage I non-seminomatous germ cell tumors of the testis managed by retroperitoneal lymphadenectomy. J Urol 116:63-65, 1976
14. Bredael JJ, Vugrin D, Whitmore WF Jr: Selected experience with surgery and combination chemotherapy in the treatment of nonseminomatous testis tumors. J Urol 129:985-988, 1983
15. Jacobs EM, Muggia FM: Testicular cancer: Risk factors and the role of adjuvant chemotherapy. Cancer 45:1782-1790, 1980
16. Vogelzang NJ, Fraley EE, Lange PH, et al: Stage II nonseminomatous testicular cancer: A 10-year experience. J Clin Oncol 1:171-178, 1983
17. Vugrin D, Whitmore W, Cvitkovic E, et al: Adjuvant chemotherapy with VAB-3 of stage II-B testicular cancer. Cancer 48:233-237, 1981
18. Vugrin D, Cvitkovic E, Whitmore WF Jr, et al: VAB-4 combination chemotherapy in the treatment of metastatic testis tumors. Cancer 47:833-839, 1981
19. Vugrin D, Whitmore WF Jr, Herr HW, et al: VAB-6 combination chemotherapy in resected stage II-B testis cancer. Cancer 51:5-8, 1983
20. Weissbach L, Hartlapp JH: Adjuvant chemotherapy of metastatic stage II nonseminomatous testis tumor. J Urol 146:1295-1298, 1991
21. Richie JP, Kantoff PW: Is adjuvant chemotherapy necessary for patients with stage B1 testicular cancer? J Clin Oncol 9:1393-1396, 1991
22. Skinner DG, Scardino PT: Relevance of biochemical tumor markers and lymphadenectomy in management of non-seminomatous testis tumors: Current perspective. J Urol 123:378-382, 1980
23. Williams SD, Stablein DM, Einhorn LH, et al: Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer. N Engl J Med 317:1433-1438, 1987
24. Vugrin D, Whitmore WF Jr, Herr H, et al: Adjuvant vinblastine, actinomycin D, bleomycin, cyclophosphamide and cisplatinum chemotherapy regimen with and without maintenance in patients with resected stage IIB testis cancer. J Urol 128:715-717, 1982
25. Hartlapp JH, Weissbach L, Bussar-Maatz R: Adjuvant chemotherapy in nonseminomatous testicular tumour stage II. Int J Androl 10:277-284, 1987
26. Pizzocaro G, Monfardini S: No adjuvant chemotherapy in selected patients with pathologic stage II nonseminomatous germ cell tumors of the testis. J Urol 131:677-680, 1984
27. Fraley EE, Narayan P, Vogelzang NJ, et al: Surgical treatment of patients with stages I and II nonseminomatous testicular cancer. J Urol 134:70-73, 1985
28. Bajorin DF, Geller NL, Weisen SF, et al: Two-drug therapy in patients with metastatic germ cell tumors. Cancer 67:28-32, 1991
29. Williams SD, Birch R, Einhorn LH, et al: Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide. N Engl J Med 316:1435-1440, 1987
30. Motzer RJ, Sheinfeld J, Mazumdar M, et al: Etoposide and cisplatin adjuvant therapy for patients with pathologic stage II germ cell tumors. J Clin Oncol 13:2700-2704, 1995
31. Pizzocaro G, Piva L, Salvioni R, et al: Adjuvant chemotherapy in resected stage-II nonseminomatous germ cell tumors of testis. In which cases is it necessary? Eur Urol 10:151-158, 1984
32. Behnia M, Foster R, Einhorn LH, et al: Adjuvant bleomycin, etoposide and cisplatin in pathological stage II non-seminomatous testicular cancer. The Indiana University experience. Eur J Cancer 36:472-475, 2000
33. Rabbani F, Sheinfeld J, Farivar-Mohseni H, et al: Low-volume nodal metastases detected at retroperitoneal lymphadenectomy for testicular cancer: Pattern and prognostic factors for relapse. J Clin Oncol 19:2020-2025, 2001